Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, Takuya, Perez-Potti, André, Rivera-Ballesteros, Olga, Strålin, Kristoffer, Gorin, Jean-Baptiste, Olsson, Annika, Llewellyn-Lacey, Sian, Kamal, Habiba +70 more·2020·Cell
Cited by (1,002)
Items 701–800 of 1,002
- Control of an Epidemic With Endogenous Treatment Capability Under Popular Discontent and Social FatigueFouad El Ouardighi, Eugene Khmelnitsky, SURESH P. SETHI · 2020 · Production and Operations Management
- Impact of Anti-Type 2 Inflammation Biologic Therapy on COVID-19 Clinical Course and OutcomeDimitri Poddighe, Elena Fedorovna Kovzel · 2021 · Journal of Inflammation Research
- Immune features of COVID-19 convalescent individuals revealed by a single-cell RNA sequencingPing-Sen Zhao, J. Zou, Fan Zhou, Yanyan Zhu, Q. Song, Dong-Dong Yu, Xiang-Pan Li · 2021 · International Immunopharmacology
- Long-Lived Immunity in SARS-CoV-2-Recovered Children and Its Neutralizing Capacity Against OmicronJustyna Sieber, Margareta Mayer, Klara Schmidthaler, Sonja Kopanja, Jeremy Vann Camp, Amelie Popovitsch, Varsha Dwivedi, Jakub Hoz, Anja Schoof, Lukas Weseslindtner et al. · 2022 · Frontiers in Immunology
- Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic MiceAnran Shen, Xiaoxiao Jin, Tao‐Tao Tang, Yan Ding, Xiao-Tao Liu, Xin Zhong, Yandan Wu, Xuelian Han, Guangyu Zhao, Chuanlai Shen et al. · 2022 · International Journal of Nanomedicine
- Publication trends of research on COVID-19 and host immune response: A bibliometric analysisYun Qiang Xia, Ren-qi Yao, Pengyue Zhao, Zhengbo Tao, Liyu Zheng, Huiting Zhou, Yong-ming Yao, Xuemin Song · 2022 · Frontiers in Public Health
- SARS-CoV-2 infection and immune responsesRakhi Harne, Brittany Williams, Hazem F. M. Abdelaal, Susan L. Baldwin, Rhea N. Coler · 2023 · AIMS Microbiology
- Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: a 20-month longitudinal studyAstrid Korning Hvidt, Huaijian Guo, Rebecca Andersen, Stine Sofie Frank Nielsen, Line K. Vibholm, Ole Schmeltz Søgaard, Marianne Hoegsbjerg Schleimann, Victoria Rose Russell, Angela M. Cheung, Eustache Paramithiotis et al. · 2023 · BMC Immunology
- The Interaction of Natural and Vaccine-Induced Immunity with Social Distancing Predicts the Evolution of the COVID-19 PandemicM. Good, M. Hawkes · 2020 · mBio
- SARS-CoV-2-Specific T Cell Responses in Patients with COVID-19 and Unexposed IndividualsMin‐Seok Rha, A Reum Kim, Eui‐Cheol Shin · 2021 · Immune Network
- Aging and CMV Infection Affect Pre-existing SARS-CoV-2-Reactive CD8+ T Cells in Unexposed IndividualsNorihide Jo, Rui Zhang, Hideki Ueno, Takuya Yamamoto, Daniela Weiskopf, Miki Nagao, Shinya Yamanaka, Yoko Hamazaki · 2021 · Frontiers in Aging
- Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna M. Horner, Alyssa D. Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri et al. · 2022 · JCI Insight
- A comprehensive assessment of long-term SARS-CoV-2–specific adaptive immune memory in convalescent COVID-19 Solid Organ Transplant recipientsAlexandre Favà, Laura Donadeu, Thomas Jouvé, José González‐Costello, Laura Lladó, Carolina Santana, Néstor Toapanta, Manuel Comabella, Vincent Pernin, Carme Facundo et al. · 2022 · Kidney International
- Versatile live-attenuated SARS-CoV-2 vaccine platform applicable to variants induces protective immunityYoshida, Akiho, Okamura, Shinya, Torii, Shiho, Komatsu, Sayuri, Miyazato, Paola, Sasaki, Hitomi, Ueno, Shiori, Suzuki, Hidehiko, Kamitani, Wataru, Ono, Chikako et al. · 2022 · iScience
- Sterilizing Immunity against COVID-19: Developing Helper T cells I and II activating vaccines is imperativeIsaac Kyei-Barffour, Samuel Akwetey Addo, E. Aninagyei, George Ghartey-Kwansah, D. O. Acheampong · 2021 · Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
- Ancestral SARS-CoV-2-specific T cells cross-recognize OmicronYu Gao, Curtis Cai, Alba Grifoni, Thomas R Müller, Julia Niessl, Anna Olofsson, Marion Humbert, Lotta Hansson, Anders Österborg, Peter Bergman et al. · 2022 · Nature Medicine
- A case-report of widespread pulmonary embolism in a middle-aged male seven weeks after asymptomatic suspected COVID 19 infectionMats O. Beckman, Sven Nyrén, Anna Kistner · 2020 · Thrombosis Journal
- Immune response to COVID-19 in older adultsMladen Jergović, Christopher P. Coplen, Jennifer L. Uhrlaub, Janko Nikolich‐Žugich · 2021 · The Journal of Heart and Lung Transplantation
- Current scenario of COVID-19 vaccinations and immune response along with antibody titer in vaccinated inhabitants of different countriesAsim Hussain, Hamza Rafeeq, Hafiza Memoona Asif, Sumaira Shabbir, Muhammad Bilal, Sikandar Imamsab Mulla, Marcelo Franco, Hafiz M.N. Iqbal · 2021 · International Immunopharmacology
- SARS-CoV-2-specific T cells generated for adoptive immunotherapy are capable of recognizing multiple SARS-CoV-2 variantsArchana Panikkar, Katie E. Lineburg, Jyothy Raju, Keng Yih Chew, George R. Ambalathingal, Sweera Rehan, Srividhya Swaminathan, Pauline Crooks, Laëtitia Le Texier, Leone Beagley et al. · 2022 · PLoS Pathogens
- Using Dual Toll-like Receptor Agonism to Drive Th1-Biased Response in a Squalene- and α-Tocopherol-Containing Emulsion for a More Effective SARS-CoV-2 VaccineKristopher K. Short, Stephanie K. Lathrop, Clara J. Davison, Haley A. Partlow, Johnathan A. Kaiser, Rebekah D. Tee, Elizabeth B. Lorentz, Jay T. Evans, David J. Burkhart · 2022 · Pharmaceutics
- The deciphering of the immune cells and marker signature in COVID‐19 pathogenesis: An updateSaade Abdalkareem Jasim, Roaa Salih Mahdi, Dmitry Olegovich Bokov, Mazin A. A. Najm, Guzal N. Sobirova, Zarnigor Orifovna Bafoeva, Ahmed Taifi, Ola Kamal A. Alkadir, Yasser Fakri Mustafa, Rasoul Mirzaei et al. · 2022 · Journal of Medical Virology
- Development of a T Cell-Based COVID-19 Vaccine Using a Live Attenuated Influenza Vaccine Viral VectorИсакова-Сивак Ирина Николаевна, Ekaterina Stepanova, Victoria Matyushenko, Sergei Niskanen, Daria А. Mezhenskaya, Ekaterina A. Bazhenova, Elena V. Krutikova, Tatiana S. Kotomina, Прокопенко Полина Игоревна, Bogdan Neterebskii et al. · 2022 · Vaccines
- Severe Acute Respiratory Syndrome Coronavirus 2 Serosurveillance in a Patient Population Reveals Differences in Virus Exposure and Antibody-Mediated Immunity According to Host Demography and Healthcare SettingEllen C. Hughes, Julien A R Amat, Joanne Haney, Yasmin A. Parr, Nicola A. Logan, Norah E. Palmateer, Sema Nickbakhsh, Antonia Ying Wai Ho, Peter Cherepanov, Annachiara Rosa et al. · 2020 · The Journal of Infectious Diseases
- Combination of a Sindbis-SARS-CoV-2 Spike Vaccine and αOX40 Antibody Elicits Protective Immunity Against SARS-CoV-2 Induced Disease and Potentiates Long-Term SARS-CoV-2-Specific Humoral and T-Cell ImmunityA. Scaglione, S. Opp, A. Hurtado, C. Pampeno, Ziyan Lin, Maria G. Noval, Sara A. Thannickal, Kenneth A. Stapleford, D. Meruelo · 2021 · bioRxiv
- The danger of the single storyline obfuscating the complexities of managing SARS‐CoV‐2/COVID‐19Joachim Peter Sturmberg, Élisabeth Paul, Wim V. Damme, Valéry Ridde, Garrett Wallace Brown, Andreas Kalk · 2021 · Journal of Evaluation in Clinical Practice
- Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19Thaís Garcias Moreira, Christian D. Gauthier, Liam Murphy, Toby Black Lanser, Anu Paul, Kimble Teixeira Fonseca Matos, Davide Mangani, Saef Izzy, Rafael Machado Rezende, Brian C. Healy et al. · 2023 · Proceedings of the National Academy of Sciences
- SARS-CoV-2 specific memory B cells frequency in recovered patient remains stable while antibodies decay over timeAnna Vaisman‐Mentesh, Yael Dror, Ran Tur‐Kaspa, Dana Markovitch, Tatiana Kournos, Dror Dicker, Yariv Wine · 2020 · medRxiv
- First year with COVID-19: Assessment and prospectsRobert N. Bergquist, Behzad Kiani, Samuel Manda · 2020 · Geospatial health
- Phenotypes and Functions of SARS-CoV-2-Reactive T CellsMin Kyung Jung, Eui‐Cheol Shin · 2021 · Molecules and Cells
- A clinicopathological description of COVID ‐19‐induced chilblains ( COVID ‐toes) correlated with a published literature reviewAthanassios Kolivras, Curtis T. Thompson, Ievgenia Pastushenko, Marisa Mathieu, P. Bruderer, M. de Vicq de Cumptich, Francesco Feoli, Saadia Harag, Isabelle Meiers, Cathérine Olemans et al. · 2021 · Journal of Cutaneous Pathology
- Protracted yet Coordinated Differentiation of Long-Lived SARS-CoV-2-Specific CD8+ T Cells during ConvalescenceTongcui Ma, Heeju Ryu, Matthew M. McGregor, Benjamin R. Babcock, Jason A. Neidleman, Guorui Xie, Ashley F. George, Julie Frouard, Victoria Murray, Gurjot Gill et al. · 2021 · The Journal of Immunology
- Autoantibodies and autoimmune disorders in SARS-CoV-2 infection: pathogenicity and immune regulationThiviya Darmarajan, Keshav Raj Paudel, Mayuren Candasamy, Jestin Chellian, Thiagarajan Madheswaran, Lakshmana Prabu Sakthivel, Bey Hing Goh, Piyush Kumar Gupta, Niraj Kumar Jha, Hari Prasad Devkota et al. · 2022 · Environmental Science and Pollution Research
- Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273Niels J. M. Verstegen, Ruth R. Hagen, Jet van den Dijssel, Lisan H Kuijper, Christine Kreher, Thomas M. Ashhurst, Laura Y. L. Kummer, Maurice Steenhuis, Mariël C Duurland, Rivka de Jongh et al. · 2022 · eLife
- Adaptive immune responses and cytokine immune profiles in humans following prime and boost vaccination with the SARS-CoV-2 CoronaVac vaccineChan Wang, Songhao Yang, Liangwei Duan, Xiancai Du, Jia Tao, Yana Wang, Jihui Yang, Yongxue Lv, Junliang Li, Cuiying Zhang et al. · 2022 · Virology Journal
- Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccinationTakuto Nogimori, Koichiro Suzuki, Yuji Masuta, Mika Yagoto, Mami Ikeda, Yuki Katayama, Ayaka Washizaki, Hidenori Kanda, Minoru Takada, Shohei Minami et al. · 2023 · Frontiers in Immunology
- SARS-CoV-2 spike-specific TFH cells exhibit unique responses in infected and vaccinated individualsRongzhang He, Xingyu Zheng, Jian Zhang, Bo Liu, Qijie Wang, Qian Wu, Ziyan Liu, Fangfang Chang, Yabin Hu, Ting Xie et al. · 2023 · Signal Transduction and Targeted Therapy
- High frequencies of alpha common cold coronavirus/SARS-CoV-2 cross-reactive functional CD4+ and CD8+ memory T cells are associated with protection from symptomatic and fatal SARS-CoV-2 infections in unvaccinated COVID-19 patientsPierre-Gregoire A. Coulon, Swayam Prakash, Nisha Rajeswari Dhanushkodi, Ruchi Srivastava, Latifa Zayou, Delia F. Tifrea, Robert A. Edwards, Cesar J. Figueroa, Sebastian Dominik Schubl, Lanny L. Hsieh et al. · 2024 · Frontiers in Immunology
- Initial COVID-19 severity influenced by SARS-CoV-2-specific T cells imprints T-cell memory and inversely affects reinfectionGang Yang, Jinpeng Cao, Jian Qin, Xinyue Mei, Shidong Deng, Yingjiao Xia, Jun Zhao, Junxiang Wang, Tao Luan, Daxiang Chen et al. · 2024 · Signal Transduction and Targeted Therapy
- A single administration of hIL-7-hyFc induces long-lasting T-cell expansion with maintained effector functionsSojeong Kim, Sang Won Lee, June‐Young Koh, Donghoon Choi, Minkyu Heo, Jae‐Yong Chung, Byung Ha Lee, Se Hwan Yang, Young Chul Sung, Howard Lee et al. · 2022 · Blood Advances
- Cellular and humoral responses after second and third SARS-CoV-2 vaccinations in patients with autoimmune diseases treated with rituximab: specific T cell immunity remains longer and plays a protective role against SARS-CoV-2 reinfectionsNatalia Egri, Hugo Calderón, Roberto Martínez-Soler, Mario Vazquez, Verónica Gómez‐Caverzaschi, Mariona Pascal, Olga Araújo, Manel Juan, Europa Azucena González‐Navarro, José Hernández‐Rodríguez · 2023 · Frontiers in Immunology
- SARS-CoV-2-specific T cell memory is long-lasting in the majority of convalsecent COVID-19 individualsZiwei Li, Jing Liu, Hui-Hong Deng, Xuecheng Yang, Hua Wang, Xuemei Feng, Gennadiy Zelinskyy, M. Trilling, K. Sutter, Meng-Ji Lu et al. · 2020 · bioRxiv
- Clinical, virologic and immunologic features of a mild case of SARS-CoV-2 reinfectionPauline Vetter, Samuel Cordey, Manuel Schibler, Laure Vieux, Lena Després, Florian Laubscher, Diego O. Andrey, Romain Martischang, Stephan Harbarth, Clémence Cuvelier et al. · 2021 · Clinical Microbiology and Infection
- SARS-CoV-2-specific Cell-mediated Immunity in Kidney Transplant Recipients Recovered From COVID-19Mario Fernández‐Ruiz, Beatriz Olea, Estela Giménez, Rocío Laguna‐Goya, Hernando Trujillo, Fernando Caravaca‐Fontán, Eduardo Gutiérrez, Francisco López‐Medrano, María José Remigia, Patricia Almendro-Vázquez et al. · 2021 · Transplantation
- Adaptive immunity to human coronaviruses is widespread but low in magnitudeHyon‐Xhi Tan, Wen Shi Lee, Kathleen M. Wragg, Christina Nelson, Robyn Esterbauer, Hannah G. Kelly, Thakshila H. Amarasena, Robert M. Jones, Graham Starkey, Bao Zhong Wang et al. · 2021 · Clinical & Translational Immunology
- Approach to SARS-CoV-2 Vaccination in Patients With Multiple SclerosisChristina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen · 2021 · Frontiers in Immunology
- Foxp3+ CD4+ regulatory T cells control dendritic cells in inducing antigen-specific immunity to emerging SARS-CoV-2 antigensRyuta Uraki, Masaki Imai, Mutsumi Ito, Hiroaki Shime, Mizuyu Odanaka, Moe Okuda, Yoshihiro Kawaoka, Sayuri Yamazaki · 2021 · PLoS Pathogens
- Utility of Bulk T-Cell Receptor Repertoire Sequencing Analysis in Understanding Immune Responses to COVID-19Hannah Kockelbergh, Shelley C. Evans, Tong Deng, Ella Clyne, Anna Kyriakidou, Andreas Economou, Kim Ngan Luu Hoang, Stephen Woodmansey, Andrew D. Foers, Anna Fowler et al. · 2022 · Diagnostics
- Breakthrough COVID-19 Infections in the US: Implications for Prolonging the PandemicDonald J. Alcendor, Patricia Matthews-Juarez, Duane T. Smoot, James E. K. Hildreth, Kimberly D. Lamar, Mohammad Tabatabai, Derek M. Wilus, Paul D. Juárez · 2022 · Vaccines
- Bioinformatic and Experimental Analysis of T Cell Immune Reactivity to SARS-CoV-2 and its VariantsAlison Tarke, Alba Grifoni, Alessandro Sette · 2022 · Frontiers in Bioinformatics
- Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospitalVidya Avinash Arankalle, A. G. Kulkarni, Ruta Kulkarni, Sonali Hemant Palkar, Rahul Patil, Jitendra Oswal, Sanjay Kewalchand Lalwani, Akhilesh Chandra Mishra · 2022 · Frontiers in Immunology
- Immune repertoire sequencing reveals an abnormal adaptive immune system in COVID‐19 survivorsChen Jia, Zhi-Guo Zhou, Wenjing Pan, Pan Zhang, Ming Yang, Ming Zhao, Bo Li, Ping Liu, Qian-Qian Zhang, Xiang-long Kong et al. · 2022 · Journal of Medical Virology
- SARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ TransplantsDavid B. Reeg, Maike Hofmann, Christoph Neumann‐Haefelin, Robert Thimme, Hendrik Luxenburger · 2023 · Pathogens
- Testing for SARS-CoV-2: lessons learned and current use casesElitza S. Theel, James E. Kirby, Nira R. Pollock · 2024 · Clinical Microbiology Reviews
- COVID-19: from immune response to clinical interventionZheng-yang Guo, Yanqing Tang, Zi-bo Zhang, Juan Liu, Yuxin Zhuang, Ting Li · 2024 · Precision Clinical Medicine
- Distinctive evolution of alveolar T cell responses is associated with clinical outcomes in unvaccinated patients with SARS-CoV-2 pneumoniaNikolay S. Markov, Ziyou Ren, Karolina J. Senkow, Rogan A. Grant, Catherine A. Gao, Elizabeth S. Malsin, Lango Sichizya, Hermon G. Kihshen, Kathryn A. Helmin, Milica Jovisic et al. · 2024 · Nature Immunology
- Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated MiceEva Fisher, Laura Padula, Kristin Podack, Katelyn Elizabeth O’Neill, Matthew M. Seavey, Padmini Jayaraman, Rahul R. Jasuja, Nataša Štrbo · 2021 · Frontiers in Immunology
- Compounds of plants with activity against SARS-CoV-2 targetsDiorge Jônatas Marmitt, Márcia Inês Goettert, Claudete Rempel · 2021 · Expert Review of Clinical Pharmacology
- Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Based Novel Epitopes Induce Potent Immune Responses in vivo and Inhibit Viral Replication in vitroPreeti Vishwakarma, Naveen Yadav, Zaigham Abbas Rizvi, N. Khan, A. Chiranjivi, Shailendra Mani, M. Bansal, Prabhanjan Dwivedi, T. Shrivastava, Rajesh Kumar et al. · 2021 · Frontiers in Immunology
- A reasoned approach towards administering COVID‐19 vaccines to pregnant womenAngsumita Pramanick, Abhiram Kanneganti, Jing Lin Jeslyn Wong, Sarah Weiling Li, Pooja Sharma Dimri, Aniza Puteri Mahyuddin, Sailesh Kumar, Sebastian Enrique Illanes, Jerry Kok Yen Chan, Lin Su et al. · 2021 · Prenatal Diagnosis
- A Peptide Vaccine Candidate Tailored to Individuals' Genetics Mimics the Multi-Targeted T Cell Immunity of COVID-19 Convalescent SubjectsEszter Somogyi, Zsolt Csiszovszki, Levente Molnár, Orsolya Lőrincz, József Tóth, Sofie Pattijn, Jana Schockaert, Aurélie Mazy, István Miklós, Katalin Pántya et al. · 2021 · Frontiers in Genetics
- BNT162b2 mRNA COVID-19 vaccine Reactogenicity: The key role of immunityPilar Vizcarra, Johannes Häemmerle, Héctor Velasco, Tamara Velasco, Marina Fernández-Escribano, Alejandro Vallejo, José L. Casado · 2021 · Vaccine
- Complexity of immune responses in COVID-19Michael William Mather, Laura Jardine, Benjamin James Talks, Louis C. S. Gardner, Muzlifah A. Haniffa · 2021 · Seminars in Immunology
- An update on host immunity correlates and prospects of re-infection in COVID-19Neema Negi, Shesh Prakash Maurya, Ravinder Singh, Bimal Kumar Das · 2021 · International Reviews of Immunology
- Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal CohortHoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, Sotheary Sann, Nisa Ya, Polidy Pean, Philippe Dussart et al. · 2022 · Frontiers in Immunology
- The Polarity and Specificity of Antiviral T Lymphocyte Responses Determine Susceptibility to SARS-CoV-2 Infection in Patients with Cancer and Healthy IndividualsJean‐Eudes Fahrner, Imran Lahmar, Anne‐Gaëlle Goubet, Yacine Haddad, Agathe Carrier, Marine Mazzenga, Damien Drubay, Carolina Alves Costa Silva, Lyon COVID Study Group, Eric de Sousa et al. · 2022 · Cancer Discovery
- Evaluating the Immune Response in Treatment-Naive Hospitalised Patients With Influenza and COVID-19Jelmer Legebeke, Jenny Lord, Rebekah Penrice-Randal, Andrés F. Vallejo, Stephen Poole, Nathan James Brendish, Xiaofeng Dong, Catherine S. Hartley, John W. Holloway, Jane S. Lucas et al. · 2022 · Frontiers in Immunology
- Immune response to SARS-CoV-2 mRNA vaccination and booster dose in patients with multiple myeloma and monoclonal gammopathies: impact of Omicron variant on the humoral responsePaola Storti, Valentina Marchica, Rosanna Vescovini, Valentina Franceschi, Luca Russo, Vincenzo Raimondi, Denise Toscani, Jessica Burroughs-Garcìa, Federica Costa, Benedetta Dalla Palma et al. · 2022 · OncoImmunology
- Modelling optimal lockdowns with waning immunityAditya Goenka, Lin Liu, Manh‐Hung Nguyen · 2022 · Economic Theory
- Mechanistic insight into the protective and pathogenic immune-responses against SARS-CoV-2Prabhat Kumar Purbey, Koushik Roy, Sandeep Gupta, Manash Kumar Paul · 2023 · Molecular Immunology
- Prime hAd5 Spike + Nucleocapsid Vaccination Induces Ten-Fold Increases in Mean T-Cell Responses in Phase 1 Subjects that are Sustained Against Spike VariantsPeter A. Sieling, Thomas B. King, Raymond M.H. Wong, Andy Nguyen, Kamil Wnuk, Elizabeth Gabitzsch, Adrian Rice, Helty Adisetiyo, Melanie Hermreck, Mohit Verma et al. · 2021 · medRxiv
- COVID-19 and earlier pandemics, sepsis, and vaccines: A historical perspectiveCavaillon, Jean-Marc, Osuchowski, Marcin F. · 2021 · Journal of Intensive Medicine
- COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?Claudio Giuseppe Gallo, Sirio Fiorino, Giovanni Posabella, Donato Antonacci, Antonio Tropeano, Emanuele Pausini, Carlotta Pausini, Tommaso Guarniero, Wandong Hong, Enrico Giampieri et al. · 2021 · Cytokine
- Late incidence of SARS-CoV-2 infection in a highly-endemic remote rural village. A prospective population-based cohort studyÓscar H. Del Brutto, Aldo F. Costa, Robertino M. Mera, Bettsy Y. Recalde, Javier Arturo Bustos, Hector Hugo Garcia · 2020 · Pathogens and Global Health
- COVID-19 and a Green Recovery?Aditya Goenka, Lin Liu, Manh‐Hung Nguyen · 2021 · Economic Modelling
- Chilblain-Like Lesions during COVID-19 Pandemic: The State of the ArtAndrea Bassi, Teresa Palmira Russo, Giuseppe Argenziano, Carlo Mazzatenta, Elisabetta Venturini, Iria Neri, Vincenzo Piccolo · 2021 · Life
- Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19Maria Laura De Angelis, Federica Francescangeli, Rachele Rossi, Alessandro Giuliani, Ruggero D. Maria, Ann Zeuner · 2021 · Viruses
- Clinical Patterns and Morphology of COVID-19 DermatologyRitesh V. Agnihothri, Lindy Peta Fox · 2021 · Dermatologic Clinics
- Association of lymphocyte subsets with mortality in severe COVID‐19 pneumonia patientsFarzaneh Ashrafi, Pardis Nematollahi, Mehrzad Salmasi, Arash Hedayat, Babak Amra · 2021 · Journal of Clinical Laboratory Analysis
- Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in miceHui‐Tsu Lin, Cheng-Cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-An Chen, Jenn‐jong Young, Szu-Cheng Kuo · 2021 · International Journal of Biological Macromolecules
- A Thermostable Oral SARS-CoV-2 Vaccine Induces Mucosal and Protective ImmunityBertrand Bellier, Alicia Saura, Lucas A. Luján, Cecilia R. Molina, Hugo Daniel Luján, David Klatzmann · 2022 · Frontiers in Immunology
- Preserved T cell responses to SARS-CoV-2 in anti-CD20 treated multiple sclerosisTatjana Schwarz, Carolin Otto, Terry C. Jones, Florence C. Pache, Patrick Schindler, Moritz A. Niederschweiberer, Felix Schmidt, Christian Drosten, Victor M. Corman, Klemens Ruprecht · 2022 · Multiple Sclerosis Journal
- Coordinated innate and T-cell immune responses in mild COVID-19 patients from household contacts of COVID-19 cases during the first pandemic waveAlessandra Aiello, Adriano Grossi, Silvia Meschi, Marcello Meledandri, Valentina Vanini, Linda Petrone, Rita Casetti, Gilda Cuzzi, Andrea Salmi, Anna Maria Gerarda Altera et al. · 2022 · Frontiers in Immunology
- Cellular and humoral response to the fourth BNT162b2 mRNA COVID‐19 vaccine dose in patients with CLLOhad Benjamini, Rotem Gershon, Erez Bar‐Haim, Yaniv Lustig, Hila Cohen, Ram Doolman, Meirav Kedmi, Elena Ribakovsky, Abraham Kneller, Tammy Hod et al. · 2022 · European Journal Of Haematology
- Association of cellular immunity with severity of COVID-19 from the perspective of antigen-specific memory T cell responses and cross-reactivityShin‐ichiro Fujii, Satoru Yamasaki, Tomonori Iyoda, Kanako Shimizu · 2022 · Inflammation and Regeneration
- SARS-CoV-2 Omicron BA.4/BA.5 Mutations in Spike Leading to T Cell Escape in Recently Vaccinated IndividualsMaarten E. Emmelot, Martijn W. Vos, Mardi C. Boer, Nynke Y. Rots, Cécile A. C. M. van Els, Patricia Kaaijk · 2022 · Viruses
- A systemic review of T-cell epitopes defined from the proteome of SARS-CoV-2Xiaoxiao Jin, Xiaotao Kelvin Liu, Chuanlai Shen · 2022 · Virus Research
- Durability of immune responses to SARS-CoV-2 infection and vaccinationMehul S. Suthar · 2024 · Seminars in Immunology
- Immune Response Resetting as a Novel Strategy to Overcome SARS-CoV-2–Induced Cytokine StormAlexandre Eduardo Nowill, Pedro Otavio de Campos-Lima · 2020 · The Journal of Immunology
- Convalescent Plasma against COVID-19: A Broad-Spectrum Therapeutic Approach for Emerging Infectious DiseasesMarijn Thijssen, Timothy Devos, Hanieh‐Sadat Ejtahed, Samad Amini‐Bavil‐Olyaee, Ali Akbar Pourfathollah, Mahmoud Reza Pourkarim · 2020 · Microorganisms
- Running to Stand Still: Naive CD8+ T Cells Actively Maintain a Program of QuiescenceTaylah J. Bennett, Vibha Udupa, Stephen T. Turner · 2020 · International Journal of Molecular Sciences
- Application of newly developed SARS-CoV2 serology test along with real-time PCR for early detection in health care workers and on-time plasma donationMohammad Sadegh Soltani‐Zangbar, Leili Aghebati Maleki, Mahsa Hajivalili, Mostafa Haji-Fatahaliha, Roza Motavalli, Ata Mahmoodpoor, Hossein Samadi Kafil, Sara Farhang, Ramin Pourakbari, Farhad Jadidi‐Niaragh et al. · 2021 · Gene Reports
- Analysis of TCR Repertoire by High-Throughput Sequencing Indicates the Feature of T Cell Immune Response after SARS-CoV-2 InfectionYifan Wang, Fu‐Gang Duan, Zhu Zhu, Meng Yu, Xiaodong Jia, Hui Dai, Pingzhang Wang, Xiaoyan Qiu, Yinying Lu, Jing Huang · 2021 · Cells
- Implications of the Immune Polymorphisms of the Host and the Genetic Variability of SARS-CoV-2 in the Development of COVID-19Jesús Zepeda–Cervantes, Daniel Martínez-Flores, Josué O. Ramírez‐Jarquín, Ángeles C. Tecalco-Cruz, Noé Santiago Alavez-Pérez, Luis A. Vaca, Rosa Elena Sarmiento Silva · 2022 · Viruses
- Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysisMaría Julia Ruiz, Gabriel Siracusano, Andréa Cottignies-Calamarte, Daniela Tudor, Fernando Real, Aiwei Zhu, Claudia Pastori, Claude Capron, Arielle R. Rosenberg, Nigel James Temperton et al. · 2022 · Frontiers in Immunology
- Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccineVanessa Gauttier, Aurore Morello, Isabelle Girault, Caroline Mary, Lyssia Belarif, Ariane Desselle, Emmanuelle Wilhelm, Thomas Bourquard, Sabrina Pengam, Géraldine Teppaz et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- Complete Protection of Nasal and Lung Airways Against SARS-CoV-2 Challenge by Antibody Plus Th1 Dominant N- and S-Specific T-Cell Responses to Subcutaneous Prime and Thermally-Stable Oral Boost Bivalent hAd5 Vaccination in an NHP StudyElizabeth Gabitzsch, Jeffrey T. Safrit, Mohit Verma, Adrian Rice, Peter A. Sieling, Lise Zakin, Annie Shin, Brett Morimoto, Helty Adisetiyo, Raymond M.H. Wong et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
- The benefits of Lactiplantibacillus plantarum: From immunomodulator to vaccine vectorJoshua Tobias, Stefan Heinl, Kristina Dendinovic, Ajša Ramić, Anna Marlene Schmid, Catherine Daniel, Ursula Wiedermann · 2025 · Immunology Letters
- Risk Factors for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection and Presence of Anti–SARS-CoV-2 Antibodies Among University Student Dormitory Residents, September–November 2020Hannah E. Segaloff, Devlin Cole, Hannah G. Rosenblum, Christine C. Lee, Clint N. Morgan, Patrick Remington, Collin Pitts, Patrick Kelly, Jake Baggott, Allen Bateman et al. · 2021 · Open Forum Infectious Diseases
- The (apparent) antibody paradox in COVID-19Rohan Ameratunga, See‐Tarn Woon, Edward Lea, Richard Henderson Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology